FinanceMoneycontrol
Buy Ajanta Pharma; target of Rs 3730: Prabhudas Lilladher
in5points
Prabhudas Lilladher has given a 'buy' rating on Ajanta Pharma.
The target price is Rs 3730 per share.
The recommendation is from a research report dated July 31, 2026.
